MedTrace Logo

Predictive Score for Maxillary Osteonecrosis After Invasive Oral Surgery

NCT04257721 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-11-26

No results posted yet for this study

Summary

Non-interventional prospective multicentre cohort study to determine a predictive score for the occurrence of osteochimionecrosis of the jaws after invasive oral surgery in patients who have received biphosphonates or antangiogenic drugs as part of chemotherapy with malignant bone disease (multiple myeloma or bone metastasis of a solid tumour).

Data are collected during the usual follow-up of patients during the first 3 months following surgery.

Conditions

  • Osteonecrosis Due to Drugs, Jaw

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Emeline Noaillon, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2022-04-06
Completion
2022-04-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04257721 on ClinicalTrials.gov